We observed a robust CD4+ proliferative response against KLH in all patients, comparable to previous studies in colorectal cancer and melanoma patients who were vaccinated with the same vaccine without chemotherapy (Figure 4A) (de Vries et al, 2003, 2005a; Lesterhuis et al, 2006). The gene discussed is CD4; the disease is melanoma.